Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells

Author(s): Banerjee K, Mohr L, Wands JR, de la Monte SM

Abstract

Chronic ethanol toxicity impairs liver regeneration, inhibits DNA synthesis, and mutes cellular responses to growth factor stimulation. Previous studies demonstrated that the adverse effects of ethanol are mediated by inhibition of tyrosyl phosphorylation of the insulin receptor and the insulin receptor substrate-type 1 (IRS-1). However, overexpression of IRS-1 leads to increased DNA synthesis and cellular transformation due to constitutive activation of mitogen-activated protein (MAP) kinase. The present study examines the effects of ethanol on insulin signaling through IRS-1 in FOCUS hepatocellular carcinoma cells, which overexpress IRS-1, to determine whether such cells were resistant to the inhibitory effects of ethanol. The results demonstrated that ethanol treatment (100 mM) caused 30 to 50% reductions in the levels of insulin-stimulated tyrosyl phosphorylation of the insulin receptor beta-subunit, tyrosyl phosphorylation of IRS-1, phosphorylation of Erk2, association of phosphatidylinositol-3 kinase with tyrosyl-phosphorylated IRS-1, and MAP kinase and phosphatidylinositol-3 kinase activities. In contrast, ethanol treatment had no effect on epidermal growth factor-stimulated tyrosyl phosphorylation of Shc. Corresponding with the pronounced inhibition of MAP kinase, ethanol treatment resulted in 30 to 50% reductions in the expression levels of two important insulin-responsive genes: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and proliferating cell nuclear antigen (PCNA). The findings suggest that, in FOCUS hepatocellular carcinoma cells, which overexpress IRS-1, ethanol treatment substantially inhibits IRS-1 and MAP kinase signaling and growth-associated gene expression, but has no effect on Shc phosphorylation, which activates p21ras through an IRS-1 independent pathway.

Similar Articles

Fetal alcohol spectrum disorders: an overview

Author(s): Riley EP, Infante MA, Warren KR

Regulation of neuronal survival by the serine-threonine protein kinase Akt

Author(s): Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, et al.

Partial rescue of ethanol-induced neuronal apoptosis by growth factor activation of phosphoinositol-3-kinase

Author(s): de la Monte SM, Ganju N, Banerjee K, Brown NV, Luong T, et al.

Acute ethanol exposure inhibits insulin signaling in the liver

Author(s): He J, de la Monte S, Wands JR

Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver

Author(s): Yeon JE, Califano S, Xu J, Wands JR, De La Monte SM

Frizzled signaling and the developmental control of cell polarity

Author(s): Shulman JM, Perrimon N, Axelrod JD

Roles of Wnt proteins in neural development and maintenance

Author(s): Patapoutian A, Reichardt LF

Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1

Author(s): Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL, Grosschedl R

Wnt signalling required for expansion of neural crest and CNS progenitors

Author(s): Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S

Wnt signaling regulates hepatic metabolism

Author(s): Liu H, Fergusson MM, Wu JJ, Rovira II, Liu J, et al.

Wnt signaling regulates mitochondrial physiology and insulin sensitivity

Author(s): Yoon JC, Ng A, Kim BH, Bianco A, Xavier RJ, et al.

Structural and functional characterization of the Wnt inhibitor APC membrane recruitment 1 (Amer1)

Author(s): Tanneberger K, Pfister AS, Kriz V, Bryja V, Schambony A, et al.

Deconstructing the ßcatenin destruction complex: mechanistic roles for the tumor suppressor APC in regulating Wnt signaling

Author(s): Roberts DM, Pronobis MI, Poulton JS, Waldmann JD, Stephenson EM, et al.

Notch in the vertebrate nervous system: an old dog with new tricks

Author(s): Pierfelice T, Alberi L, Gaiano N

Notch targets and their regulation

Author(s): Bray S, Bernard F

Roles of bHLH genes in neural stem cell differentiation

Author(s): Kageyama R, Ohtsuka T, Hatakeyama J, Ohsawa R

Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma

Author(s): Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, et al.

Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness

Author(s): de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, et al.

Impaired placentation in fetal alcohol syndrome

Author(s): Gundogan F, Elwood G, Longato L, Tong M, Feijoo A, et al.

Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility

Author(s): Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, et al.

AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis

Author(s): Roy HK, Olusola BF, Clemens DL, Karolski WJ, Ratashak A, et al.

Wnt signaling function in Alzheimer's disease

Author(s): De Ferrari GV, Inestrosa NC